Table 1.
Clinicopathological characteristics in the patients with serous epithelial ovarian cancer (EOC) and Annexin A10 (ANXA10) expression.
| Characteristic | Number | Percent |
|---|---|---|
| Age (years) | ||
| <50 | 30 | 25.42% |
| ≥50 | 88 | 74.58% |
| Lymph node metastasis | ||
| No | 75 | 63.56% |
| Yes | 43 | 36.44% |
| Histological grade | ||
| 1 | 16 | 13.56% |
| 2 | 45 | 38.14% |
| 3 | 57 | 48.31% |
| Response to chemotherapy | ||
| Good | 78 | 66.10% |
| Poor | 40 | 33.90% |
| Cytoreduction status | ||
| Optimal | 63 | 53.39% |
| Suboptimal | 55 | 46.61% |
| FIGO stage | ||
| I+II | 58 | 49.15% |
| III+IV | 60 | 50.85% |
| ANXA10 | ||
| Low | 73 | 61.86% |
| High | 45 | 38.14% |
FIGO – International Federation of Gynecology and Obstetrics.